ZYBAN

This brand name is authorized in Australia, Brazil, Canada, France, Ireland, Israel, Netherlands, New Zealand, Poland, Romania, South Africa, Turkey, UK.

Active ingredients

The drug ZYBAN contains one active pharmaceutical ingredient (API):

1	Bupropion UNII ZG7E5POY8O - BUPROPION HYDROCHLORIDE
	Bupropion is a selective inhibitor of the neuronal re-uptake of catecholamines (noradrenaline and dopamine) with minimal effect on the re-uptake of indolamines (serotonin) and does not inhibit either monoamine oxidase. The mechanism by which bupropion enhances the ability of patients to abstain from smoking is unknown. However, it is presumed that this action is mediated by noradrenergic and/or dopaminergic mechanisms.
	Read more about Bupropion

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ZYBAN Prolonged release tablet	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N06AX12	Bupropion	N Nervous system → N06 Psychoanaleptics → N06A Antidepressants → N06AX Other antidepressants
Discover more medicines within N06AX12

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	8465M, 8710K
BR	Câmara de Regulação do Mercado de Medicamentos	510609401113315
CA	Health Products and Food Branch	02238441
FR	Base de données publique des médicaments	64556383
GB	Medicines & Healthcare Products Regulatory Agency	147460, 164536, 19231, 373482
IE	Health Products Regulatory Authority	29211, 56054
IL	מִשְׂרַד הַבְּרִיאוּת	4212
NL	Z-Index G-Standaard, PRK	53643
NZ	Medicines and Medical Devices Safety Authority	8829
PL	Rejestru Produktów Leczniczych	100094624
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W65215001, W65215002
TR	İlaç ve Tıbbi Cihaz Kurumu	8699522036073
ZA	Health Products Regulatory Authority	34/34/0374